Botox has been used off-label for this indication, but the FDA approval should help with reimbursement. Botox was FDA-approved for upper-limb spasticity in 2010 (#msg-47616915).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”